Effects in The ApoB/ApoA-I Ratio Using Rosuvastatin and Atorvastatin in Patients With Acute Coronary Syndrome

Clinical trial NCT00296387 · COMPLETED

Trial details

NCT number: NCT00296387
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Coronary Syndrome

Start date: 2006-01-01
Enrollment: 1160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.